Option Care Health (NASDAQ:OPCH – Get Free Report) will announce its earnings results before the market opens on Wednesday, October 30th. Analysts expect the company to announce earnings of $0.31 per share for the quarter. Option Care Health has set its FY 2024 guidance at EPS.Investors interested in listening to the company’s conference call can do so using this link.
Option Care Health (NASDAQ:OPCH – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the firm posted $0.63 EPS. The business’s revenue was up 14.8% compared to the same quarter last year. On average, analysts expect Option Care Health to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Option Care Health Stock Down 1.0 %
NASDAQ OPCH opened at $29.45 on Monday. Option Care Health has a twelve month low of $26.11 and a twelve month high of $34.63. The stock has a market cap of $5.12 billion, a PE ratio of 19.38, a PEG ratio of 2.31 and a beta of 1.29. The firm has a 50-day simple moving average of $31.00 and a 200 day simple moving average of $30.07. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.36 and a current ratio of 1.76.
Insider Buying and Selling at Option Care Health
Analysts Set New Price Targets
OPCH has been the subject of a number of research reports. JMP Securities raised their price objective on Option Care Health from $36.00 to $37.00 and gave the stock a “market outperform” rating in a research report on Monday, September 30th. Barrington Research reiterated an “outperform” rating and set a $40.00 price target on shares of Option Care Health in a research note on Wednesday, October 23rd.
View Our Latest Stock Report on Option Care Health
About Option Care Health
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
- Five stocks we like better than Option Care Health
- Top Biotech Stocks: Exploring Innovation Opportunities
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Dividend Capture Strategy: What You Need to Know
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.